3JAMESON J N, KASPER D L, HARRISON T R, et al. Harrison's principles of internal medicine[M]. 16th ed. New York: McGraw-Hill Medical Publishing Division,2005 : ISBN 0--07-- 140235 -- 7.
4PIMENTA J M, ALMEIDA R, ARAUJO J P ,et al. Amino terminal B-type natriuretic peptide, renal function, and prognosis in acute heart failure: A hospital cohort study. J Cardiac Fail, 2007, 13, 275--280.
5CODD M B, SUGRUE D D, GERSH B J, et al. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy: a population based study in Olmstead county[J]. Circulation, 1989,80 : 564- 572.
6MIURA K, NAKAGAWA H, MORIKAWA Y, et al. Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey [J].Heart, 2002,87 : 126 -- 130.
7SILVERBERG D, WEXLER D, BLUM M, et al. The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both the cardiac and renal function and reduce hospitalization[J]. Clin Nephrol, 2003, 60(Suppl 1) : S93--S102.
8HEYWOOD J T. The eardiorenal syndrome., lessons from the ADHERE database and treatment options [J].Heart FailRev,2004, 9: 195--201.
9RONCO C, HAAPIO M, HOUSE A A, et al. Cardiorenal syndrome[J]. J Am Coll Cardiol, 2008,52 : 1527 --1539.
10ROBB K, JOSEPH R, ANDREW S. Organ cross talk in the critically III: The heart and kidney[J]. Blood Purif, 2009,27 : 311 -- 320.
